Current Issues in the Enzymology of Mitomycin C Metabolic Activation
- 1 October 1998
- journal article
- review article
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 31 (4) , 539-544
- https://doi.org/10.1016/s0306-3623(98)00055-x
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Bioactivation of mitomycin antibiotics by aerobic and hypoxic Chinese hamster ovary cells overexpressing DT-diaphoraseBiochemical Pharmacology, 1996
- Reductase Enzyme Expression Across the National Cancer Institute Tumor Cell Line Panel: Correlation With Sensitivity to Mitomycin C and EO9JNCI Journal of the National Cancer Institute, 1996
- Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPH:cytochrome c (P-450) reductase.Proceedings of the National Academy of Sciences, 1996
- Re-evaluation of the molecular pharmacology of mitomycin CEuropean Journal Of Cancer, 1995
- Conversion of mitomycin C to 2,7-diaminomitosene and 10-decarbamoyl 2,7-diaminomitosene in tumour tissue in vivoCancer Chemotherapy and Pharmacology, 1995
- Bioreductive drugs for cancer therapy: The search for tumor specificityInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Encapsulation of mitomycin C in albumin microspheres markedly alters pharmacokinetics, drug quinone reduction in tumour tissue and antitumour activity: Implications for the drugs' in vivo mechanism of actionBiochemical Pharmacology, 1994
- Reductive Activation of Mitomycin C: A Delicate BalanceJNCI Journal of the National Cancer Institute, 1992
- Polycyclic aromatic hydrocarbon quinone-mediated oxidation reduction cycling catalyzed by a human placental NADPH-linked carbonyl reductaseArchives of Biochemistry and Biophysics, 1991
- Reductive activation of mitomycin CBiochemistry, 1988